3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
7
Wilms Tumor
6
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Multiple Myeloma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Lung Neoplasms
4
Central Nervous System Neoplasms
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Mycosis Fungoides
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Temozolomide
22
Radiotherapy
9
Radiation
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
4
Lomustine
4
Bevacizumab
4
Nivolumab
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
olaparib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Ipilimumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
varlilumab
1
ulixertinib
1
tinostamustine
1
temsirolimus
1
selinexor
1
ruxolitinib
1
ribociclib
1
relatlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
X-Rays
×
30 days
×
Clear all
No trials found.